These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 2082129
1. Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents. Li KC, Ang PG, Tart RP, Storm BL, Rolfes R, Ho-Tai PC. Magn Reson Imaging; 1990; 8(5):589-98. PubMed ID: 2082129 [Abstract] [Full Text] [Related]
4. [Oral contrast media for magnetic resonance tomography of the abdomen. 1. Comparative animal studies of positive and negative contrast media]. Laniado M, Kaminsky S, Semmler W, Weinmann HJ, Zurth C, Claussen C. Rofo; 1987 Sep; 147(3):325-32. PubMed ID: 2445010 [Abstract] [Full Text] [Related]
5. [MR imaging oral contrast agent mixed with milk for the small intestine]. Hirohashi S, Hirohashi R, Uchida H, Kitano S, Tanaka M, Matsuo N, Ohishi H. Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul 25; 54(8):784-8. PubMed ID: 8072869 [Abstract] [Full Text] [Related]
6. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas]. Neumann K, Kaminsky S, Gogoll M, Clauss W, Langer M, Felix R. Rofo; 1991 Mar 25; 154(3):262-8. PubMed ID: 1849293 [Abstract] [Full Text] [Related]
7. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT. Low RN, Francis IR. AJR Am J Roentgenol; 1997 Oct 25; 169(4):1051-9. PubMed ID: 9308464 [Abstract] [Full Text] [Related]
8. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA]. Kaminsky S, Laniado M, Gogoll M, Kornmesser W, Clauss W, Felix R. Rofo; 1992 Jan 25; 156(1):17-23. PubMed ID: 1733470 [Abstract] [Full Text] [Related]
9. Yb-DTPA, a novel contrast agent in magnetic resonance imaging: application to rat kidney. Sarkar SK, Rycyna RE, Lenkinski RE, Solleveld HA, Kinter LB. Magn Reson Med; 1991 Feb 25; 17(2):328-35. PubMed ID: 2062207 [Abstract] [Full Text] [Related]
11. Use of nutritional support formula as a gastrointestinal contrast agent for MRI. Mirowitz SA, Susman N. J Comput Assist Tomogr; 1992 Feb 25; 16(6):908-15. PubMed ID: 1430440 [Abstract] [Full Text] [Related]
12. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide. Chang CA. Invest Radiol; 1993 Mar 25; 28 Suppl 1():S21-7. PubMed ID: 8486500 [No Abstract] [Full Text] [Related]
15. Pathologic conditions in the small bowel: findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Faber SC, Stehling MK, Holzknecht N, Gauger J, Helmberger T, Reiser M. Radiology; 1997 Oct 25; 205(1):278-82. PubMed ID: 9315000 [Abstract] [Full Text] [Related]
16. Clinical use of contrast media in magnetic resonance imaging. Bydder GM. Br J Hosp Med; 1990 Feb 25; 43(2):149-52. PubMed ID: 2178714 [Abstract] [Full Text] [Related]